Junji Ichikawa
Junji Ichikawa publishes mostly in Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology, on topics such as Neurotransmitter Receptor Influence on Behavior, Schizophrenia research and treatment and Receptor Mechanisms and Signaling.
- World rank
- #1,294,724 of 7,710,434 ranked researchers
- Rank in United States
- #412,010 of 1,627,098
- Works
- 35
- Citations
- 4k
- Citations per work
- 115.6
What does Junji Ichikawa research?
Junji Ichikawa's work is mostly in Neuroscience (40%), Medicine (39%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1954.3%
- Health Sciences1439.0%
- Medicine1439.0%
- Everything else26.7%
- 1Cellular and Molecular Neuroscience40% of their works
- 2Psychiatry and Mental health26% of their works
- 3Molecular Biology14% of their works
- 4Pharmacology6% of their works
- 5Neurology4% of their works
- 6Pediatrics, Perinatology and Child Health4% of their works
Research topics
- Neurotransmitter Receptor Influence on Behavior
- Schizophrenia research and treatment
- Receptor Mechanisms and Signaling
- Neuroscience and Neuropharmacology Research
- Bipolar Disorder and Treatment
- Pharmacological Effects and Toxicity Studies
- Treatment of Major Depression
- Parkinson's Disease Mechanisms and Treatments
Which keywords describe Junji Ichikawa's research?
The keywords of their largest research topics: Dopamine, Serotonin, Antipsychotic Drugs, Neurocognitive Deficits, Synaptic Plasticity, Crystal Structure, G-Protein-Coupled Receptors and GABAergic.
- Parkinson's Disease
- Depression
- Antidepressant
- Bipolar Spectrum Disorder
- Cognitive Function
- GABAergic
- Crystal Structure
- Neurocognitive Deficits
- Serotonin
- Dopamine
- Antipsychotic Drugs
- Synaptic Plasticity
- G-Protein-Coupled Receptors
- Neurotransmission
- Oxidative Stress
- Prevalence
- Antiepileptic Drugs
- Prenatal Exposure
- a-Synuclein
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Dopamine281 topic
- Serotonin281 topic
- Antipsychotic Drugs191 topic
- Neurocognitive Deficits191 topic
- Synaptic Plasticity182 topics
- Crystal Structure151 topic
- G-Protein-Coupled Receptors151 topic
- GABAergic141 topic
- Neurotransmission141 topic
- Cognitive Function102 topics
- Oxidative Stress72 topics
- Bipolar Spectrum Disorder61 topic
- Prevalence61 topic
- Antidepressant41 topic
- Antiepileptic Drugs41 topic
- Depression41 topic
- Prenatal Exposure41 topic
- Parkinson's Disease31 topic
- a-Synuclein31 topic
Where does Junji Ichikawa work?
Junji Ichikawa's main affiliation in the publication record is Vanderbilt University, United States.
How many publications and citations does Junji Ichikawa have?
OpenAlex counts 35 works and 4,046 citations for Junji Ichikawa, an h-index of 30, ranking #1,294,724 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Junji Ichikawa
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Junji Ichikawa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.